Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit

Journal of Orthopaedic Research

Volumn 26, Issue 6, 2008, Pages 785-792

  Giavaresi, Gianluca ^a   Borsari, Veronica ^a   Fini, Milena ^d   Giardino, Roberto ^a   Sambri, Vittorio ^b   Gaibani, Paolo ^b   Soffiatti, Renzo ^c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Tecres SpA   (Italy)

^d NONE

Author keywords

Gentamicin vancomycin coating; Intramedullary infections; PMMA nail

Indexed keywords

GENTAMICIN; MELOXICAM; POLY(METHYL METHACRYLATE); TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOMATERIAL; STAINLESS STEEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE INFECTION; BONE NAIL; COMPARATIVE STUDY; CONTROLLED STUDY; DEBRIDEMENT; DRUG DELIVERY SYSTEM; HISTOLOGY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; ANIMAL; BIOFILM; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; FEMUR FRACTURE; INFECTION; MULTIMODALITY CANCER THERAPY; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; BONE NAILS; COATED MATERIALS, BIOCOMPATIBLE; COMBINED MODALITY THERAPY; DEBRIDEMENT; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; FEMORAL FRACTURES; GENTAMICINS; MALE; METHICILLIN RESISTANCE; OSTEOMYELITIS; POLYMETHYL METHACRYLATE; PROSTHESIS-RELATED INFECTIONS; RABBITS; STAINLESS STEEL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 46449135220     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20543     Document Type: Article

References (51)

1. Madanagopal SG, Seligson D, Roberts CS. 2004. The antibiotic cement nail for infection after tibial nailing. Orthopedics 27: 709-712.
2. Babin SR, Graf P, North J, et al. 1981. Infection following closed intramedullary nailing by Kuntscher's method in 1059 fractures [in French]. Int Orthop 5:271-276.
3. Klemm KW. 1986. Treatment of infected pseudarthrosis of the femur and tibia with an interlocking nail. Clin Orthop 212:174-181.
4. Paley D, Herzenberg JE, Bor N. 1997. Fixator-assisted nailing of femoral and tibial deformities. Tech Orthop 12:260-275.
5. Simpson AH, Cole AS, Kenwright J. 1999. Leg lengthening over an intramedullary nail. J Bone Joint Surg Br 81:1041-1045.
6. Brandt CM, Sistrunk WW, Duffy MC, et al. 1997. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24: 914-919.
7. Koort JK, Makinen TJ, Suokas E, et al. 2005. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 49: 1502-1508.
8. Toma MB, Smith KM, Martin CA, et al. 2006. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Orthopedics 29:497-501.
9. Sims M, Saleh M. 2000. External fixation - the incidence of pin site infection: a prospective audit. J Orthop Res 4:59-63.
10. Lazzarini L, Mader JT, Calhoun JH. 2004. Osteomyelitis in Long Bones. J Bone Joint Surg Am 86:2305-2318.
11. Le Ray AM, Gautier H, Laty MK, et al. 2005. In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsilon-caprolactone) microparticles. Antimicrob Agents Chemother 49:3025-3027.
12. An YH, Friedman RJ. 1998. Animal models of orthopaedic prosthetic infection. In: An YH, Friedman RJ, editors. Animal models in orthopaedic research. Boca Raton, FL: CRC-Taylor & Francis; p 443-456.
13. Shirtliff ME, Calhoun JH, Mader JT. 2002. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop Rel Res 201:239-247.
14. Faber C, Hoogendoorn RJ, Stallmann HP, et al. Skeletal Tissue Engineering Group Amsterdam (STEGA). 2004. In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model. J Antimicrob Chemother 54: 1078-1084.
15. Faber C, Stallmann HP, Lyaruu DM, et al. 2005. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11and gentamicin in a chronic methcillin-resistant Staphylococcus aureus osteomyelitis model. Antimicrob Agents Chemother 49:2438-2444.
16. Joosten U, Joist A, Gosheger G, et al. 2005. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronica osteomyelitis. Biomaterials 26:5251-5258.
17. Mendel V, Simanowski HJ, Scholz HC, et al. 2005. Therapy with gentamicin - PMMA beads, gentamicin - collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch Orthop Trauma Surg 125:363-368.
18. Chen A, Hou C, Bao J, et al. 1999. Antibiotic loaded chitosan bar. Clin Orthop 366:239-247.
19. Rutledge B, Huyette D, Day D, et al. 2003. Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer. Clin Orthop Rel Res 411:280-287.
20. Hendricks KJ, Lane D, Burd TA, et al. 2001. Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clin Orthop Relat Res 392:418-426.
21. Makinen TJ, Veiranto M, Lankinen P, et al. 2005. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063-1068.
22. Turner TM, Urban RM, Hall DJ, et al. 2005. Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Relat Res 437:97-104.
23. Kanellakopoulou K, Tsaganos T, Athanassiou K, et al. 2006. Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study. Int J Antimicrob Agents 28:217-220.
24. Saleh Mghir A, Crémieux AC, Bleton R, et al. 1998. Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]Teicoplanin in experimental Staphylococcus aureus infection of joint prostheses. Antimicrob Agents Chemother 42: 2830-2835.
25. Bertazzoni Minelli E, Caveiari C, Benini A. 2002. Release of antibiotics from polymethylmethacrylate cement. J Chemother 14:492-500.
26. Bertazzoni Minelli E, Benini A, Magnan B, et al. 2004. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 53:329-334.
27. Bertazzoni Minelli E, Benini A. 2007. The gentamicin-vancomycin spacer: a pharmacological study. In: Meani E, Romanò C, Crosby L, Hofmann G, editors. Infection and local treatment in orthopaedic surgery. Berlin: Springer-Verlag; p 352-358.
28. Hsieh PH, Shih CH, Chang YH, et al. 2004. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 86:1989-1997.
29. Hsieh PH, Shih CH, Chang YH, et al. 2005. Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg Br 87:770-775.
30. Ismael F, Bléton R, Saleh-Mghir A, et al. 2003. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 47:3365-3367.
31. Magnan B, Regis D, Biscaglia R, et al. 2001. Preformed acrylic bone cement spacer loaded with antibiotics: use of two-stage procedure in 10 patients because of infected hips after total replacement. Acta Orthop Scand 72:591-594.
32. Shirtliff ME, Calhoun JH, Mader JT. 2002. Gatifloxacin efficacy in treatment of experimental methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits. Antimicrob Agents Chemother 46:231-233.
33. Springer BD, Lee GC, Osmon D, et al. 2004. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 427:47-51.
34. Houlihan HH, Stokes DP, Rybak MJ. 2000. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model. J Antimicrob Chemother 46:79-86.
35. Hershberger E, Aeschlimann JR, Moldovan T, et al. 1999. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods. Antimicrob Agents Chemother 43:717-721.
36. Montali A. 2006. Antibacterial coating systems. Injury Int J Care Injured 37:S81-S86.
37. Schwab JH, Pagnano M, Haidukewych GJ, et al. 2003. A technique for treating periprosthetic fracture of the femur associated with deep prosthetic infection. J Arthropalsty 18: 211-215.
38. Paley D, Herzenberg JE. 2002. Intramedullary infections treated with antibiotic cement rods: preliminary results in nine cases. J Orthop Trauma 10:723-729.
39. Klemm K, Henry S, Seligson D. 1988. The treatment of infection after interlocking nailing. Tech Orthop 3:54-61.
40. Seligson D, Klemm K. 1996. Treatment of infection following intramedullary nailing. In: Browner B, editor. The science and practice of intramedullary nailing. 2nd ed. Baltimore, MD: Williams & Wilkins; p 317-333.
41. An YH, Kang QK, Arciola CR. 2006. Animal model of osteomyelitis. Int J Artif Organs 29:407-420.
42. Woods GL, Washington JA. 1995. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington, DC: ASM Press; p 1327-1342.
43. Nordern CW, Myerowitz RL, Keleti E. 1980. Experimental osteomyelitis due to Staphylococcus aureus or psedomonas aeruginosa: a radiographic-pathological correlative analysis. Br J Exp Pathol 61:451-460.
44. Smeltzer MS, Thomas JR, Hickmon SG, et al. 1997. Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res 15:414-421.
45. Ochsner PE, Hailemariam S. 2006. Histology of osteosynthesis associated bone infection. Injury Int J Care Injured 37:S49-S58.
46. Jansen B, Peters G, Pulverer G. 1988. Mechanisms and clinical relevance of bacterial adhesion to polymers. J Biomater Appl 2:520-543.
47. Cordero J, Garcia-Cimbrelo E. 2000. Mechanisms of bacterial resistance in implant infection. Hip Int 10:139-144.
48. Norden CW, Niedereiter K, Shinners EM. 1986. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin. Infection 14:103-110.
49. Schulz S, Steinhart H, Mutters R. 2001. Chronic osteomyelitis in a new rabbit model. J Invest Surg 14:121-131.
50. Cordero J, Munuera L, Folgueira MD. 1996. The influence of the chemical composition and surface of the implant on infection. Injury 27:S34-S37.
51. Kendall RW, Duncan CP, Smith JA, et al. 1996. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin Orthop Relat Res 329:273-280.